WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 7401 Infant (under 12 months) mortality rate: 972
GDP / capita (US$): 1'4931 Child (under 5 years) mortality rate: 1692

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 12'448  12'080  11'721  11'371  11'031  8'301  5'952  4'513 
Births 579  569  558  546  535  426  304  225 
Surviving infants 523  512  501  490  479  378  267  195 
Pop. less than 5 years 2'406  2'353  2'292  2'239  2'189  1'683  1'177  859 
Pop. less than 15 years 6'050  5'889  5'724  5'575  5'424  4'065  2'826  2'034 
Female 15-49 years 2'699  2'607  2'522  2'434  2'351  1'767  1'277  1'001 

Number of reported case

(Click for retrospective incidence data for Chad)
Diphtheria
Japanese encephalitis
Measles 120  8'650  194  165  63  3'546  7'226 
Mumps
Pertussis
Polio* 17  132  27  64  37  60 
Rubella
Rubella (CRS)
Tetanus (neonatal) 225  215  279  146  163  142  738 
Tetanus (total) 215  146  163  1'603 
Yellow fever 48  122  79 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Chad)
Vaccine year result method % card seen                                                
BCG 2011  68  EPI   41.0  79  79  84  72  57  50 
DTP1 2011  55  EPI   41.0  93  94  100  95  74  45 
DTP3 2011  42  EPI   41.0  72  70  83  75  43  28  20 
HepB_BD         
HepB3 2011  42  EPI   41.0  72  70  83  75  17 
Hib3 2011  42  EPI   41.0  72  70  83  75  17 
JapEnc         
MCV 2011  54  EPI   41.0  69  79  84  87  54  42 
MCV2         
PCV1         
PCV3         
Pol3 2011  52  EPI   41.0  73  67  75  68  41  29  16 
Rota1         
Rota_last         
Rubella1         
TT2plus 2009  38  MICS   21.3  70  60  77  61  57  12 
PAB         
VAD1         
YFV 2011  45  EPI   41.0  70  80  82  79  53  36 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Chad)
BCG 63  53  58  46  30  49  59 
DTP1 64  55  55  45  47  45  44 
DTP3 45  33  39  24  19  36  20 
HepB3 45  33  39  24  17 
Hib3 45  33  39  24  17 
MCV 64  54  46  36  27  28  32 
PAB 43  60  60  60  58  39  14 
PCV3
Pol3 56  40  43  32  30  30  20 
Rota_last
YFV 53  45  41  32  33  28 

Number of districts in the country 61  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 39
From 80 to 89% 13
From 50 to 79% 36
Less than 50% 11
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
Measles 9 months; Yes
OPV Birth; 6, 10, 14 weeks; Yes
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013 - 2017  2008 - 2012  2008-2012  2008-2012  2008 - 2012  2008 - 2012  2003-2007 
Nº of districts with microplans that include activities to raise immunization coverage number 61  61  37  35  51  32  54 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  Yes         

System performance

Total number of districts in country number 61  61  61  61  61  54  54 
Nº districts with DTP3 coverage >=80% number 32  19  33  32  19  23 
% of districts with DTP3 coverage >=80% From 0 to 100% 52  31  54  52  35  43 
Nº districts with measles (MCV1) coverage >=95% number 24  14  20  18  11     
% of districts with MCV1 coverage >=95% From 0 to 100% 39  23  33  30  18     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR No  No  No  No  No  No  No 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 24  11  65  45    80  55 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No No  No  No  No  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.